It has been reported in only a small number of transplant recipients [2,7,8,9,10,11] and in even fewer patients who have received tumor necrosis factor-alpha (TNF) inhibitors [11,12], or had hematological malignancies [7,11]. The gene discussed is TNF; the disease is hematologic disorder.